Successful Management of Malignant Pericarditis Using Nivolumab for Metastatic Esophageal Squamous Cell Carcinoma

Intern Med. 2024 Mar 1;63(5):677-680. doi: 10.2169/internalmedicine.2041-23. Epub 2023 Jul 19.

Abstract

Esophageal cancer is a malignant disease with a poor prognosis and is one of the most common causes of cardiac metastasis. Malignant pericarditis may cause the repetitive accumulation of pericardial effusion, which can occasionally pose a clinical challenge. We herein report a case of malignant pericarditis in a patient with metastatic esophageal squamous cell carcinoma with cardiac tamponade, which was successfully managed with single pericardial drainage and systemic nivolumab monotherapy. This is the first case report to suggest that systemic therapy with nivolumab is a promising option for the management of malignant pericarditis.

Keywords: cardiac tamponade; esophageal cancer; nivolumab; pericardial drainage; pericardial effusion; pericarditis.

Publication types

  • Case Reports

MeSH terms

  • Cardiac Tamponade* / drug therapy
  • Cardiac Tamponade* / etiology
  • Esophageal Neoplasms* / complications
  • Esophageal Neoplasms* / drug therapy
  • Esophageal Squamous Cell Carcinoma* / complications
  • Esophageal Squamous Cell Carcinoma* / drug therapy
  • Humans
  • Nivolumab / therapeutic use
  • Pericarditis* / diagnostic imaging
  • Pericarditis* / drug therapy
  • Pericarditis* / etiology
  • Thymus Neoplasms* / complications

Substances

  • Nivolumab